RWE in Pharma: 5 minutes with… Giovanna Barcelos

In this ‘RWE in Pharma’ interview series, we are putting various pharma experts in the spotlight and asking them to share their insight on how their industry has traditionally employed real-world evidence (RWE), how they envision this changing over the next few years and what their predictions of the impacts of the highly anticipated U.S. FDA RWE Framework may be. This installment features Giovanna Barcelos, RWE and Health Economics and Outcomes Research (HEOR) Senior Manager Europe at Global Blood Therapeutics (GBT, Zug, Switzerland). Please could you introduce yourself, your organization(s) and tell us more about your role?  My name is Giovanna Barcelos...